BioSpace News Archive

Business

Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023

Wave Life Sciences Ltd. will host a live webcast and conference call at 8:30 a.m. ET on Thursday, August 3, 2023, to review the company’s second quarter 2023 financial results and provide business updates.

July 27, 2023
·
1 min read
Drug Development

Avenue Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy’s Disease)Topline data expected in 2024

Avenue Therapeutics, Inc. today announced that the first patient has been dosed in the Phase 1b/2a clinical trial of AJ201 for the treatment of spinal and bulbar muscular atrophy (“SBMA”), also known as Kennedy’s Disease.

July 27, 2023
·
8 min read
Business

Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology

Anixa Biosciences, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance broadening protection of Anixa’s novel ovarian cancer vaccine technology, which has been exclusively licensed from, and is being developed in partnership with, Cleveland Clinic.

July 27, 2023
·
3 min read
Drug Development

Glyscend Therapeutics Announces Publication of GLY-200 First-in-Human Data and Availability of Phase 2a Clinical Results

Glyscend Therapeutics today announced that safety and pharmacodynamic data from the first-in-human Phase 1 trial of GLY-200 were published in Diabetes, Obesity and Metabolism.

July 27, 2023
·
4 min read
Business

HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time

HeartBeam, Inc. will hold a conference call on Thursday August 10, 2023 at 4:30 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2023, and will be reviewing recent announcements, ongoing initiatives, and key 2023 milestones.

July 27, 2023
·
3 min read
Business

Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call

biote Corp. today announced the Company will provide second quarter financial results on Thursday, August 10, 2023, after the close of the market.

July 27, 2023
·
3 min read
BioMidwest

NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform

NovAccess Global Inc., a biomedical company developing novel immunotherapies for brain tumor patients, announced the signing of a Letter of Intent and formation of a partnership with BCN Biosciences to expand its immunotherapy platform.

July 27, 2023
·
8 min read
Policy

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control

Femasys Inc. announced that the United States Patent and Trademark Office issued a Notice of Allowance for U.S. Patent Application 16/402,193 further strengthening Femasys’ intellectual property position and coverage for the Company’s therapeutic product candidate, FemBloc® permanent birth control.

July 27, 2023
·
4 min read
Business

IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second quarter financial results before the market opens on Thursday, August 3rd.

July 27, 2023
·
2 min read
Business

Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue

Evolus, Inc., a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, reported revenue for the second quarter ended June 30, 2023 and raised its revenue guidance for the full year.

July 27, 2023
·
6 min read